(Updated - January 6, 2023 6:27 AM EST)

Raymond James analyst Timur Ivannikov downgraded AnaptysBio (NASDAQ: ANAB) from Outperform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE